FDA Import Refusal SCS-0711082-0/21/1 — BIOPAS
The FDA refused shipment SCS-0711082-0/21/1 from BIOPAS (Colombia) on Jul 9, 2020. The refused product falls under Drugs and Biologics — LACOSAMIDE (ANTI-CONVULSANT). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Jul 9, 2020
- Country
- Colombia
- Product Category
- Drugs and Biologics
- Product Code
- 61MCA47 LACOSAMIDE (ANTI-CONVULSANT)
- Charges
- 75